Stocks TelegraphStocks Telegraph
Stock Ideas

CAH Company Profile and Key Details

NYSE : CAH

Cardinal Health

$227.18
20.33+9.83%
At Close 4:00 PM
59.06
BESG ScoreESG Rating
ProfileKey StatsAnalyst RatingsOwnershipRatiosFinancialsDividend & splitsSentimentForecast

Price Chart

Stock Price Today

Cardinal Health, Inc. (CAH) stock surged +9.83%, trading at $227.18 on NYSE, up from the previous close of $206.85. The stock opened at $217.00, fluctuating between $212.03 and $229.70 in the recent session.

Stock Snapshot

206.85
Prev. Close
53.98B
Market Cap
212.03
Day Low
31.16
P/E Ratio
7.29
EPS (TTM)
13.96
Cash Flow per Share
217
Open
237.6M
Number of Shares
229.7
Day High
99.82%
Free Float in %
-14.08
Book Value
3.58M
Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing DateAccepted Date

Annual Report (10-k)

Filing DateAccepted Date

Stock Price History Chart

DateOpenHighLowCloseVolume
Feb 05, 2026217.00229.76212.03227.183.55M
Feb 04, 2026215.52217.76205.87206.852.49M
Feb 03, 2026218.70220.27217.16218.001.83M
Feb 02, 2026215.85218.93214.50218.931.64M
Jan 30, 2026210.95214.92210.01214.882.45M
Jan 29, 2026212.46216.51210.29211.231.3M
Jan 28, 2026212.62214.33208.46210.391.49M
Jan 27, 2026210.60214.59210.01214.041.76M
Jan 26, 2026208.86212.17208.86210.931.61M
Jan 23, 2026207.04210.75206.67208.331.94M
Jan 22, 2026209.00209.84206.27206.891.55M
Jan 21, 2026209.22210.79206.32208.471.84M
Jan 20, 2026210.48213.38209.28210.371.63M
Jan 16, 2026213.62214.52212.00212.451.31M
Jan 15, 2026213.65215.48212.92213.461.56M
Jan 14, 2026208.53213.63207.85213.561.59M
Jan 13, 2026210.10212.30205.65208.261.85M
Jan 12, 2026202.00203.33199.95202.521.28M
Jan 09, 2026203.79204.34200.55201.111.25M
Jan 08, 2026207.90209.77201.67202.491.54M

Contact Details

Dublin, OH 43017

United States

https://www.cardinalhealth.com614 757 5000

About Company

Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and offers medication therapy management and patient outcomes services to hospitals, other healthcare providers, and payers, as well as provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.

Company Information

Employees47922
Beta0.65
Sales or Revenue$222.58B
5Y Sales Change%0.77%
Fiscal Year EndsJune
SectorHealthcare
IndustryMedical - Distribution

Stock Peers

MCK
135.8+16.52%
McKesson Corporation$957.80COR
22.19+6.72%
Cencora, Inc.$352.16ABC
-0.41-0.23%
AmerisourceBergen Corporation$179.98PBH
-1.48-2.21%
Prestige Consumer Healthcare Inc.$65.55GRDN
1.43+4.55%
Guardian Pharmacy Services, Inc.$32.87OMI
0.22+8.94%
Owens & Minor, Inc.$2.68ACH
-0.12-5.17%
Accendra Health, Inc.$2.20

Company Overview

Cardinal Health, Inc. (NYSE:CAH) closed at $227.18 USD, gaining $20.33 (9.83%) from the previous close of $206.85. The stock is currently within 5% of its 52-week high $120.72 and $229.70. With a market capitalization of about $53.98 billion, Cardinal Health, Inc. is classified as a large-cap and shows lower-than-market volatility (beta ~0.66). Key stats such as the average daily volume over the past year has been around 2.07 million shares, trading with heavier-than-usual volume. Headquartered in Dublin, OH, Cardinal Health, Inc. operates in the Healthcare sector and the Medical - Distribution industry. Led by CEO Jason Hollar, the company employs approximately 47,922 people and listed since August 04, 1983. Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States, Canada, Europe, Asia, and internationally.

Technical Performance

CAH has shown sold momentum, gaining 3.88% over the past week and 34.5% over the past quarter, though year-to-date performance is up 2.37%. Short-term trend indicators are bearishly aligned (SMA20 7.66%, SMA50 9.78%, SMA200 32.37%). The stock’s 14-day RSI is 65.69 (firm momentum), while the ATR of 6.15 points to higher daily volatility. The stock remains currently trading near 52-week highs, trading 3.14% below its high and over 88.19% above its low. Average 10-day trading volume of 2.06 million shares is in line with the 3-month average of 1.98 million, indicating normal recent market interest.

Valuation Metrics

Cardinal Health, Inc. trades at a P/E ratio of 32.48, slightly below the S&P 500 average, with a price-to-sales ratio of 0.22 and a price-to-book ratio of -18.72 indicating negative book value, which may reflect financial stress. The P/FCF stands at 9.87, also above market averages.

Dividend & Fair Value

Cardinal Health, Inc. last paid a dividend of 2.04 per share, this equals a trailing yield of roughly 1.82%. Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $327.01. This means the shares are trading below this model’s fair value.

Earnings & Analyst Outlook

Wall Street analysts project EPS growth of 15.54% annually over the next five years. The latest quarter delivered EPS of $2.55. The next quarter is forecast at $2.34. Next year's EPS is expected at $11.26. Analyst sentiment is bullish. Analyst rating data shows there are 14 Strong Buy ratings, 5 Buy ratings, 2 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $245.00 to $150.00. The high target offers 7.84% upside. The low target suggests -33.97% downside. The mean target is $200.71. This offers -11.65% upside. Cardinal Health, Inc. earnings surprise history is a consistent trend of beating forecasts. The quarter that ended October 30, 2025, missed forecasts by 16.97%. The prior quarter beat by 1.96%. Over the last six quarters, Apple has recorded several small beats. These include 6.98% in August 14, 2024.

Shareholding & Insider Activity

Cardinal Health, Inc. has 238.79 million shares outstanding. The public float is 238.29 million shares, elevated short interest at 4.20% of float. This equals 7.62 million shares. The short ratio is 3.38 days. Institutional investors hold 88.64% of the float. Insiders own 0.28%. Barrett George S holds 464.23 thousand shares, Kaufmann Michael C has 211.85 thousand shares and Hollar Jason M. has 200.00 thousand shares. Over the past six months, insider transactions show net selling. They sold 81.72 thousand shares across 9 transactions.

Financial & Profitability Overview

Over the trailing twelve months, Cardinal Health generated $222.58B in revenue, or $919.74 per share. Gross margin was 3.67%, operating margin 1.02%, and net profit margin 0.70%. Returns are negative, with ROA at 2.94% and ROE at -56.13%.
On valuation metrics, Cardinal Health trades at a P/E of 32.48, P/S of 0.22 and P/B of -18.72. Liquidity is tight, with a current ratio of 0.91 and quick ratio of 0.44. Operationally, the company’s inventory turnover is 11.71 and cash conversion cycle is -8.86 days , indicating it collects cash faster than it pays suppliers. Debt-to-equity is -3.13, supported by a cash flow-to-debt ratio of 0.68.

Quarterly Financial Highlights

For the quarter ended Jun 30, 2025, Cardinal Health posted revenue of $222.58B, down slightly from $226.83B in the prior quarter. Gross profit was $8.17B (margin 3.67%). Operating income was $2.28B (margin 1.0%). Net income was$1.56B (EPS $6.48).
The company ended the quarter with $3.87B in cash and short-term investments, a total debt of $9.35B, and net debt of $5.47B. Total assets were $53.12B, with equity of - $2.63B. Financials further reflected stability, with operating cash flow of $2.40B, free cash flow of $1.85B, and capital expenditures of - $547.00M.

Frequently Asked Questions

What is the current Cardinal Health, Inc. (CAH) stock price?
Cardinal Health, Inc. (NYSE: CAH) stock price is $227.18 in the last trading session. During the trading session, CAH stock reached the peak price of $229.70 while $212.03 was the lowest point it dropped to. The percentage change in CAH stock occurred in the recent session was 9.83% while the dollar amount for the price change in CAH stock was $20.33.
CAH's industry and sector of operation?
The NYSE listed CAH is part of Medical - Distribution industry that operates in the broader Healthcare sector. Cardinal Health, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Who are the executives of CAH?
Ms. Michelle Greene
Executive Vice President & Chief Information Officer
Mr. Kevin Moran
Vice President of Investor Relations
Ms. Michelle D. Greene
Executive Vice President & Chief Information Officer
Mr. Craig Cowman
Executive Vice President of Strategic Sourcing & Manufacturer Services
Ms. Patricia M. English
Senior Vice President & Interim Chief Financial Officer
Ms. Jessica L. Mayer
Chief Legal & Compliance Officer
Ms. Mary C. Scherer
Senior Vice President & Chief Accounting Officer
Ms. Ola M. Snow
Chief HR Officer
Ms. Deborah L. Weitzman
Chief Executive Officer of Pharmaceutical Distribution
Mr. Stephen M. Mason
Chief Executive Officer of Medical Segment
Mr. Jason M. Hollar
Chief Executive Officer & Director
Mr. Robert Rajalingam
Pres of U.S. Medical Products & Distribution
How CAH did perform over past 52-week?
CAH's closing price is 88.19% higher than its 52-week low of $120.72 where as its distance from 52-week high of $229.70 is -1.1%.
How many employees does CAH have?
Number of CAH employees currently stands at 47,922.
Link for CAH official website?
Official Website of CAH is: https://www.cardinalhealth.com
How do I contact CAH?
CAH could be contacted at phone 614 757 5000 and can also be accessed through its website. CAH operates from 7000 Cardinal Place, Dublin, OH 43017, United States.
How many shares of CAH are traded daily?
CAH stock volume for the day was 3.58M shares. The average number of CAH shares traded daily for last 3 months was 2.07M.
What is the market cap of CAH currently?
The market value of CAH currently stands at $53.98B with its latest stock price at $227.18 and 237.6M of its shares outstanding.
logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

HomeAboutMeet The TeamContact UsPrivacy PolicyNewsletter

Useful Links

ScreenerMarket DataInsider TransactionsUpgrades & Downgrades52 Week Highs & LowsUnusual VolumeDividend CalendarEarnings CalendarStocks Watchlist
Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph